Skip to content
PubMed This is a summary of 77 peer-reviewed journal articles Updated
Endocrinology

Infundibulo-neurohypophysitis (INH): A Patient Guide

At a Glance

Infundibulo-neurohypophysitis is a rare inflammation of the pituitary stalk that can cause severe thirst and frequent urination by disrupting the body’s water-saving hormone. MRI, blood tests, and follow-up help guide diagnosis and treatment with steroids and desmopressin.

Disclaimer: This guide provides educational information based on available medical literature, much of which consists of small observational studies. It does not replace individualized medical advice. Always consult your specialized care team (endocrinology, neuroradiology, ophthalmology, and neurosurgery) regarding your specific diagnosis and treatment.

Infundibulo-neurohypophysitis (INH) is a rare condition involving inflammation of the pituitary stalk and the back part of the pituitary gland. While the name is long and complex, it describes a specific anatomical event: your immune system or an external trigger causes swelling in the “bridge” that connects your brain to the control center for your hormones [1]. Unlike many other pituitary conditions that affect growth or metabolism, INH primarily disrupts the body’s ability to regulate water, leading to a profound and relentless thirst [2].

The most immediate challenge of living with INH is managing Arginine Vasopressin Deficiency (AVP-D). Because the inflammation damages the area responsible for releasing the hormone that tells your kidneys to save water, the body loses fluid rapidly through frequent urination. This creates a cycle where you must drink large volumes of water just to maintain basic hydration. While this can be exhausting, it is manageable with a replacement hormone called desmopressin, which helps restore the body’s natural balance and allows for better sleep and daily function [3][4].

Diagnosing INH is often a careful process of elimination. On an MRI, the inflamed pituitary stalk appears thickened, a finding that can also be seen in certain rare tumors or systemic inflammatory diseases. Because of this, your medical team must work diligently to rule out other causes through blood work and specialized imaging before confirming a diagnosis of INH [5]. This “diagnostic journey” can be a time of uncertainty, but it is a vital step in ensuring you receive the correct treatment for your specific situation [6].

Treatment usually follows two separate paths: cooling down the active inflammation and replacing the missing hormones. While medications like steroids can effectively shrink the swelling and relieve pressure in the brain, they often do not “cure” the underlying hormone deficiency, which may remain permanent [7]. For this reason, management shifts over time from addressing the initial crisis to a steady routine of hormone replacement and periodic monitoring.

Living with INH requires long-term vigilance and a close partnership with an endocrinologist. Even when the initial inflammation resolves and the pituitary stalk returns to its normal size on a scan, your care team will continue to monitor you for several years. This ongoing surveillance ensures that any late-developing hormone deficiencies are caught early and provides peace of mind that the original diagnosis remains accurate. With the right replacement therapy and consistent follow-up, most people with INH lead full, active lives [8].

Common questions in this guide

What is infundibulo-neurohypophysitis (INH)?
INH is a rare inflammation of the pituitary stalk and the back part of the pituitary gland. It can affect the hormone that tells the kidneys to conserve water, leading to extreme thirst and frequent urination.
What symptoms can INH cause?
INH can cause arginine vasopressin deficiency, which means the body loses water too quickly. Common effects include intense thirst and frequent urination, which can interfere with sleep and daily activities.
How do doctors diagnose INH?
An MRI may show a thickened pituitary stalk, but that finding can also occur with certain tumors or inflammatory diseases. Doctors usually combine MRI with blood tests and other imaging to rule out these causes before confirming INH.
How is infundibulo-neurohypophysitis treated?
Steroid medicines may reduce inflammation and swelling, while desmopressin replaces the water-saving hormone that is missing. Treatment may address both the active inflammation and the need for long-term hormone replacement, because hormone deficiency can persist after the swelling improves.
Can hormone problems from INH become permanent?
The inflammation may resolve, but the resulting hormone deficiency may remain permanent in some people. Desmopressin can manage the water-balance problem, and follow-up helps identify any additional hormone deficiencies.
How long will I need follow-up for INH?
The care team may continue checking pituitary function for several years, even if the stalk returns to its usual size on MRI. Ongoing monitoring can detect hormone deficiencies that develop later and helps confirm that the original diagnosis remains accurate.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Infundibulo-neurohypophysitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my MRI and tests, how confident are we that this is autoimmune inflammation rather than another condition?
  2. 2.What is the primary goal of our current treatment plan—shrinking the inflammation, managing my thirst, or both?
  3. 3.How will we monitor my 'anterior' pituitary hormones over time to ensure no other deficiencies develop?
  4. 4.What specific changes in my symptoms or vision should trigger an immediate call to your office between scans?
  5. 5.Who on my care team should I contact first if I develop a stomach virus and cannot keep my medications down?

References

References (8)
  1. 1

    Neuroimaging of hypophysitis: etiologies and imaging mimics.

    Kurokawa R, Kurokawa M, Baba A, et al.

    Japanese journal of radiology 2023; (41(9)):911-927 doi:10.1007/s11604-023-01417-y.

    PMID: 37010787
  2. 2

    Idiopathic Arginine Vasopressin Deficiency With Mild and Reversible Hypercalcemia.

    Malik A, Goyal A, Gupta R, Bhagat A

    Ochsner journal 2025; (25(1)):67-72 doi:10.31486/toj.24.0089.

    PMID: 40123924
  3. 3

    Clinical Factors Affecting Daily Dosage of Desmopressin Orally Disintegrating Tablets in Arginine Vasopressin Deficiency.

    Hoshino Y, Inoue K, Ikeda S, et al.

    The Journal of clinical endocrinology and metabolism 2024; (109(3)):e983-e996 doi:10.1210/clinem/dgad694.

    PMID: 38019190
  4. 4

    A case of central diabetes insipidus after COVID-19 as a probable diagnosis of lymphocytic infundibulo-neurohypophysitis with positive anti-rabphilin-3A antibodies with review of literature.

    Natsuki Y, Nagata Y, Nagasaki T, et al.

    Endocrine journal 2024; (71(12)):1165-1173 doi:10.1507/endocrj.EJ24-0093.

    PMID: 39198191
  5. 5

    Pituitary stalk thickening in patients under 18 years of age - the most common causes and diagnostic procedures.

    Moszczyńska E, Baszyńska-Wilk M, Zasada K, et al.

    Pediatric endocrinology, diabetes, and metabolism 2022; (28(3)):213-227 doi:10.5114/pedm.2022.115202.

    PMID: 35620922
  6. 6

    Etiological Spectrum and Pattern of Change in Pituitary Stalk Thickening: Experience in 321 Patients.

    Zhou X, Zhu H, Yao Y, et al.

    The Journal of clinical endocrinology and metabolism 2019; (104(8)):3419-3427 doi:10.1210/jc.2018-02297.

    PMID: 30892632
  7. 7

    Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis.

    Lupi I, Cosottini M, Caturegli P, et al.

    European journal of endocrinology 2017; (177(2)):127-135.

    PMID: 28626085
  8. 8

    Clinical presentation and outcome of children with central diabetes insipidus associated with a self-limited or transient pituitary stalk thickening, diagnosed as infundibuloneurohypophysitis.

    Schaefers J, Cools M, De Waele K, et al.

    Clinical endocrinology 2017; (87(2)):171-176 doi:10.1111/cen.13362.

    PMID: 28444954

This page is for informational purposes only and does not constitute medical advice. Your endocrinology, neuroradiology, ophthalmology, and neurosurgery team should guide decisions about INH diagnosis, treatment, and long-term monitoring.